RIKEN-NKT Trademark

Trademark Overview


On Friday, July 30, 2021, a trademark application was filed for RIKEN-NKT with the United States Patent and Trademark Office. The USPTO has given the RIKEN-NKT trademark a serial number of 79328738. The federal status of this trademark filing is REGISTERED as of Tuesday, June 27, 2023. This trademark is owned by RIKEN IMMUNE REGENERATIVE MEDICINE INC.. The RIKEN-NKT trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Cells for medical use or clinical use; cells for medical use or clinical use for treatment or prevention of cancer; cells as pharmaceutical for treatment or prevention of cancer; biological preparations for use in cell cultures for medical purposes for the treatment of cancer, immune disease, allergic disease, diabetes, myasthenia including lambert-Eaton syndrome, Parkinson's disease, renal failure, and dementia; cellular function activating agents for medical purposes; pharmaceutical preparations for activating cellular function; pharmaceutical preparations, other than agrochemicals, for the treatment of cancer, immune disease, allergic disease, diabetes, myasthenia including lambert-Eaton syndrome, Parkinson's disease, renal failure, and dementia; reagent paper for medical purposes; nutritional supplements; dietetic preparations adapted for medical purposes

Medical treatment services utilizing cell growth or cell activation and consultancy and information services relating thereof; medical treatment or prevention of cancer utilizing cell growth or cell activation and consultancy and information services relating thereof; providing medical cancer treatment and consultancy and information services relating thereof; medical services, namely, providing clinical examinations related to medical treatment and consultancy and information services relating thereof; medical services, namely, providing clinical examinations and medication thereof as well as consultancy and information services relating thereof; medical treatment services and consultancy and information services relating thereof; medical check-up services and consultancy and information services relating thereof; dental care services; provision of pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
riken-nkt

General Information


Serial Number79328738
Word MarkRIKEN-NKT
Filing DateFriday, July 30, 2021
Status700 - REGISTERED
Status DateTuesday, June 27, 2023
Registration Number7088829
Registration DateTuesday, June 27, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "RIKEN-NKT" in stylized orange font, with the letter "R" forming an orange infinity symbol to the upper left of the letter; the color white in the mark indicates background and is not claimed as a feature of the mark.
Goods and ServicesCells for medical use or clinical use; cells for medical use or clinical use for treatment or prevention of cancer; cells as pharmaceutical for treatment or prevention of cancer; biological preparations for use in cell cultures for medical purposes for the treatment of cancer, immune disease, allergic disease, diabetes, myasthenia including lambert-Eaton syndrome, Parkinson's disease, renal failure, and dementia; cellular function activating agents for medical purposes; pharmaceutical preparations for activating cellular function; pharmaceutical preparations, other than agrochemicals, for the treatment of cancer, immune disease, allergic disease, diabetes, myasthenia including lambert-Eaton syndrome, Parkinson's disease, renal failure, and dementia; reagent paper for medical purposes; nutritional supplements; dietetic preparations adapted for medical purposes
Indication of Colors claimedThe color(s) orange is/are claimed as a feature of the mark.
Goods and ServicesMedical treatment services utilizing cell growth or cell activation and consultancy and information services relating thereof; medical treatment or prevention of cancer utilizing cell growth or cell activation and consultancy and information services relating thereof; providing medical cancer treatment and consultancy and information services relating thereof; medical services, namely, providing clinical examinations related to medical treatment and consultancy and information services relating thereof; medical services, namely, providing clinical examinations and medication thereof as well as consultancy and information services relating thereof; medical treatment services and consultancy and information services relating thereof; medical check-up services and consultancy and information services relating thereof; dental care services; provision of pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 18, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRIKEN IMMUNE REGENERATIVE MEDICINE INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameRIKEN IMMUNE REGENERATIVE MEDICINE INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameRIKEN IMMUNE REGENERATIVE MEDICINE INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Sunday, November 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 29, 2023GENERIC MADRID TRANSACTION SENT TO IB
Friday, September 29, 2023GENERIC MADRID TRANSACTION CREATED
Wednesday, September 27, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, April 13, 2023NOTIFICATION PROCESSED BY IB
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 24, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 1, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 1, 2022FINAL REFUSAL E-MAILED
Thursday, September 1, 2022FINAL REFUSAL WRITTEN
Thursday, July 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 28, 2022REFUSAL PROCESSED BY IB
Wednesday, June 8, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 8, 2022REFUSAL PROCESSED BY MPU
Thursday, May 5, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 4, 2022NON-FINAL ACTION WRITTEN
Thursday, April 28, 2022ASSIGNED TO EXAMINER
Wednesday, February 2, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, February 1, 2022ASSIGNED TO LIE
Friday, January 28, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 22, 2021APPLICATION FILING RECEIPT MAILED
Saturday, December 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 16, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB